Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer
Clinical trial NCT02901301 · UNKNOWN
Trial details
- NCT number
- NCT02901301
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2020-10-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.